| |
Non OCP group
|
OCP group
|
p-value
|
|---|
|
Desensitization day
|
<6 mm follicles
|
29 [15.2-54.3]
|
26 [15.7-65.8]
|
NS
|
| |
6–9 mm follicles
|
5 [1.0-14.4]
|
6.5 [2.0-18.6]
|
NS
|
| |
LH (IU/L)
|
1.7 [0.6-4.3]
|
0.7 [0.5-2.5]
|
P = 0.0001
|
| |
Prog (ng/mL)
|
0.2 [0.1-0.6]
|
0.3 [0.1-0.6]
|
NS
|
| |
Testo (ng/mL)
|
0.19 [0.05-0.45]
|
0.23 [0.06-1.06]
|
NS
|
| |
Δ4 (ng/mL)
|
1.71 [0.86-3.13]
|
1.48 [0.74-5.40]
|
NS
|
|
D7
|
6–9 mm follicles
|
11 [2.1-30.1]
|
10 [3.9-40.5]
|
NS
|
| |
≥10 mm follicles
|
6 [1.1-17.0]
|
6 [1.0-23.0]
|
NS
|
| |
E2 (pg/mL)
|
396 [76.4-1269]
|
287 [94.7-1680.9]
|
NS
|
| |
LH (IU/L)
|
0.9 [0.5-2.4]
|
0.7 [0.3-1.1]
|
NS
|
| |
Prog (ng/mL)
|
0.3 [0.1-0.6]
|
0.3 [0.2-0.5]
|
NS
|
| |
Testo (ng/mL)
|
0.27 [0.10-0.49]
|
0.32 [0.05-0.55]
|
NS
|
| |
Δ4 (ng/mL)
|
2.01 [0.87-4.03]
|
2.05 [0.82-4.17]
|
NS
|
|
HCG-D
|
10–12 mm follicles
|
7 [3.0-13.9]
|
4 [1.0-15.0]
|
NS
|
| |
13–15 mm follicles
|
7 [2.0-23.8]
|
7 [2.0-18.2]
|
NS
|
| |
>15 mm follicles
|
8 [4.5-15.5]
|
9 [3.0-15.0]
|
NS
|
| |
E2 (pg/mL)
|
3135 [1704.0-5528.1]
|
3131 [1120.5-5859.0]
|
NS
|
| |
LH (IU/L)
|
1.4 [0.5-2.2]
|
1.0 [0.4-2.3]
|
NS
|
| |
Prog (ng/mL)
|
0.8 [0.3-2.3]
|
0.7 [0.2-1.4]
|
NS
|
| |
Testo (ng/mL)
|
0.46 [0.31-1.34]
|
0.53 [0.27-1.39]
|
NS
|
| |
Δ4 (ng/mL)
|
3.50 [1.78-7.81]
|
3.69 [1.02-6.72]
|
NS
|
- COH controlled ovarian hyperstimulation, D7 seventh day of controlled ovarian hyperstimulation, HCG-D HCG injection day, LH luteinizing hormone, Prog progesterone, Testo testosterone, Δ4 delta-4 androstenedione, E2 oestradiol. Quantitative data presented are medians [5th – 95th percentiles].
